Market Overview

Piper Jaffray Initiates Coverage on ZIOPHARM Oncology Inc at Neutral, Announces $5.00 PT

Share:

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Latest Ratings for ZIOP

DateFirmActionFromTo
Mar 2015Mizuho SecuritiesDowngradesBuyNeutral
Mar 2015Mizuho SecuritiesMaintains
Jan 2015BMO CapitalUpgradesUnderperformOutperform

View More Analyst Ratings for ZIOP
View the Latest Analyst Ratings

Posted-In: News Analyst Ratings

 

Related Articles (ZIOP)

Around the Web, We're Loving...

Get Benzinga's Newsletters